Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study

BACKGROUND: Budesonide foam is used for the topical treatment of distal ulcerative colitis. This phase III study was performed to confirm mucosal healing and other therapeutic effects of twice-daily budesonide 2-mg foam in patients with mild-to-moderate ulcerative colitis including left-sided coliti...

Descripción completa

Detalles Bibliográficos
Autores principales: Naganuma, Makoto, Aoyama, Nobuo, Tada, Tomohiro, Kobayashi, Kiyonori, Hirai, Fumihito, Watanabe, Kenji, Watanabe, Mamoru, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Original Article—Alimentary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866841/
https://www.ncbi.nlm.nih.gov/pubmed/28779419
http://dx.doi.org/10.1007/s00535-017-1376-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866841/
https://www.ncbi.nlm.nih.gov/pubmed/28779419
http://dx.doi.org/10.1007/s00535-017-1376-4

Ejemplares similares